This site is maintained for archival purposes only. New submissions, peer review, and editorial correspondence are handled through the new journal platform. Access the current journal site here.
NEW INSIGHTS INTO THE PATHOGENESIS OF OSTEOARTHRITIS
Vol. 33 No. 1 (2025), Review articles
Vol. 33 No. 1 (2025)

NEW INSIGHTS INTO THE PATHOGENESIS OF OSTEOARTHRITIS

Review articles
https://doi.org/10.35465/33.1.2025.pp36-56
Published September 28, 2025
Irina Momcheva
V Gonchev
M Valkov
PDF ENG
PDF BG (Български)

Keywords

osteoarthritis, epigenetics, methylation, DNA, RNA, histones

How to Cite

Momcheva, I., Gonchev, V., & Valkov, M. (2025). NEW INSIGHTS INTO THE PATHOGENESIS OF OSTEOARTHRITIS. Rheumatology (Bulgaria), 33(1), 36-56. https://doi.org/10.35465/33.1.2025.pp36-56
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The multifactorial pathogenesis of osteoarthritis (OA) and the diversity of its phenotypic manifestations have been subjects of discussion in recent years. This report summarizes the latest data from clinical studies regarding the pathogenesis (PG) of OA. Aspects of PG are examined, such as: the consequences of trauma, the involvement of heat shock proteins, mitochondrial dysfunction, disturbances in the JAK/STAT signaling pathway, low-grade focal inflammation, the role of different macrophage populations, telomere shortening in the aging process, and more. Special attention is given to the involvement of genetic and epigenetic factors in the multifactorial pathogenesis of osteoarthritis. These factors, through mechanisms of gene expression modulation—such as DNA methylation and demethylation, histone modifications, acetylation and deacetylation, and activation of microRNAs—contribute to either silencing or enhanced expression of genes associated with OA. In this way, fine post-transcriptional tuning is maintained, which increases resistance to chronic diseases, including OA. Knowledge of epigenetic control could provide a more in-depth, holistic understanding of the etiology and pathogenesis of OA and offer future directions for its management.

https://doi.org/10.35465/33.1.2025.pp36-56
PDF ENG
PDF BG (Български)

References

    1. Ratneswaran A, Kapoor M. Osteoarthritis year in review: genetics, genomics, epigenetics. Osteoarthritis and Cartilage 202129151–160. (10.1016/j.joca.2020.11.003)
    2. Rahmati M, Nalesso G, Mobasheri A, Mozafari M. Aging and osteoarthritis: central role of the extracellular matrix. Ageing Research Reviews 20174020–30. (10.1016/j.arr.2017.07.004)
    3. Contartese D, Tschon M, De Mattei M, Fini M. Sex specific determinants in osteoarthritis: A systematic review of preclinical studies. International Journal of Molecular Sciences 202021. (10.3390/ijms21103696)
    4. Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology (Oxford) 201857iv61–iv74. (10.1093/rheumatology/key011)
    5. Stürmer T, Günther KP, Brenner H. Obesity, overweight and patterns of osteoarthritis: the Ulm osteoarthritis Study. Journal of Clinical Epidemiology 200053307–313. (10.1016/s0895-4356(9900162-6)
    6. Ter Heegde F, Luiz AP, Santana-Varela S, Magnusdottir R, Hopkinson M, Chang Y, Poulet B, Fowkes RC, Wood JN, Chenu C. Osteoarthritis-related nociceptive behaviour following mechanical joint loading correlates with cartilage damage. Osteoarthritis and Cartilage 202028383–395. (10.1016/j.joca.2019.12.004)
    7. Thomas AC, Hubbard-Turner T, Wikstrom EA, Palmieri-Smith RM. Epidemiology of posttraumatic osteoarthritis. Journal of Athletic Training 201752491–496. (10.4085/1062-6050-51.5.08)
    8. Kuusalo L, Felson DT, Wang N, Lewis CE, Torner J, Nevitt MC, Neogi T. & Multicenter Osteoarthritis Study Group. Metabolic osteoarthritis - relation of diabetes and cardiovascular disease with knee osteoarthritis. Osteoarthritis and Cartilage 202129230–234. (10.1016/j.joca.2020.09.010)
    9. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 201251249–257. (10.1016/j.bone.2012.02.012); Woodell-May JE, Sommerfeld SD. Role of inflammation and the immune system in the progression of osteoarthritis. Journal of Orthopaedic Research 202038253–257. (10.1002/jor.24457
    10. Xie J, Wang Y, Lu L, Liu L, Yu X, Pei F. Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications. Ageing Research Reviews 202170 101413. (10.1016/j.arr.2021.101413)
    11. Sun K, Jing X, Guo J, Yao X, Guo F. Mitophagy in degenerative joint diseases. Autophagy 2021172082 2092. (10.1080/15548627.2020.1822097)
    12. Mehana EE, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review. Life Sciences 2019234 116786. (10.1016/j.lfs.2019.116786)
    13. Yang CY, Chanalaris A, Troeberg L. LADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'. Osteoarthritis and Cartilage 2017251000–1009. ( 10.1016/j.joca.2017.02.791
    14. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Annals of the New York Academy of Sciences 20101192230–237. (10.1111/j.1749-6632. 2009.05240.x
    15. Van der Kraan PM, van den Berg WB. Osteophytes: relevance and biology. Osteoarthritis and Cartilage200715237–244. (10.1016/j.joca.2006.11.006)
    16. Madry H, Kon E, Condello V, Peretti GM, Steinwachs M, Seil R, Berruto M, Engebretsen L, Filardo G, Angele P. Early osteoarthritis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy 2016241753–1762. (10.1007/s00167-016-4068-3
    17. Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. International Journal of Molecular Sciences 20131419805–19830. (10.3390/ijms141019805
    18. Abraham AC, Pauly HM, Donahue TL. Deleterious effects of osteoarthritis on the structure and function of the meniscal enthesis. Osteoarthritis and Cartilage 201422275–283. (10.1016/j.joca.2013.11.013)
    19. Schulze-Tanzil G.Intraarticular ligament degeneration is interrelated with cartilage and bone destruction in osteoarthritis. Cells 20198. (10.3390/cells8090990)
    20. Shorter E, Sannicandro AJ, Poulet B, Goljanek-Whysall K. Skeletal muscle wasting and its relationship with osteoarthritis: a mini-review of mechanisms and current interventions. Current Rheumatology Reports 201921 40. (10.1007/s11926-019-0839-4
    21. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, Zuurmond AM, Stojanovic-Susulic V, Bridts C, de Clerck L, DeGroot J, Verhaar JA, Kloppenburg M al. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Annals of the Rheumatic Diseases 201271288–294. (10.1136/ard.2011.153858)
    22. Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7:33–42
    23. Su Z.-Q., et al., Chest 156 (5) (2019) 915.
    24. Hu Y., et al., Bone Research 9 (1) (2021) 20.
    25. Hu W., et al., Ann. Rheum. Dis. 80 (4) (2021) 413.
    26. Singh-Jasuja, H., N. Hilf, D. Arnold-Schild, H. Schild. 2001. The role of heat shock proteins and their receptors in the activation of the immune system. Biol. Chem. 382: 629-636.
    27. Kabalyk M. A., Age-Related Aspects of the Involvement of Heat Shock Proteins in the Pathogenesis of Osteoarthritis, 01. March. 2018, Volume 7, pages 274-280, Advanses in Gerontology
    28. Ngarmukos S, Scaramuzza S, Theerawattanapong N, Tanavalee A, Honsawek S. Circulating and Synovial Fluid Heat Shock Protein 70 Are Correlated with Severity in Knee Osteoarthritis. Cartilage. 2020 Jul;11(3):323-328. doi: 10.1177/1947603518790075. Epub 2018 Jul 19. PMID: 30024275; PMCID: PMC7298593.
    29. O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med (2015) 66:311–28. doi: 10.1146/annurev-med-051113-024537
    30. Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, et al.. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol (2020) 80:106210. doi: 10.1016/j.intimp.2020.106210
    31. Namba A, Aida Y, Suzuki N, Watanabe Y, Kawato T, Motohashi M, et al.. Effects of IL-6 and soluble IL-6 receptor on the expression of cartilage matrix proteins in human chondrocytes. Connect Tissue Res (2007) 48(5):263–70. doi: 10.1080/03008200701587513
    32. Weng LH, Ko JY, Wang CJ, Sun YC, Wang FS. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints. Arthritis Rheum (2012) 64(10):3267–77. doi: 10.1002/art.34602
    33. Blasioli DJ, Kaplan DL. The roles of catabolic factors in the development of osteoarthritis. Tissue Eng Part B Rev (2014) 20(4):355–63. doi: 10.1089/ten.TEB.2013.0377
    34. Larsson R, Bernhardsson S, Nordeman L. Effects of eccentric exercise in patients with subacromial impingement syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2019 Oct 14;20(1):446. doi: 10.1186/s12891-019-2796-5. PMID: 31610787; PMCID: PMC6792214.
    35. Latourte A, Cherifi C, Maillet J, Ea HK, Bouaziz W, Funck-Brentano T, et al. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis. Ann Rheum Dis (2017) 76(4):748–55. doi: 10.1136/annrheumdis-2016-209757
    36. Liu J, Dong X, Liu Y, Wang K, Lei S, Yang M, et al. The identified hub gene GlcN in osteoarthritis progression and treatment. Comput Math Methods Med (2021) 2021:5499450. doi: 10.1155/2021/5499450
    37. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. association with a down-regulation of SOX9 expression. J Biol Chem (2003) 278(5):2903–12. doi: 10.1074/jbc.M110773200
    38. Gyurkovska V, Stefanova T, Dimitrova P, Danova S, Tropcheva R, Ivanovska N. Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice. Inflammation (2014) 37(4):995–1005. doi: 10.1007/s10753-014-9820-6
    39. Maldonado M, Nam J. The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013; 2013:284873
    40. Assirelli E, Pulsatelli L, Dolzani P, Platano D, Olivotto E, Filardo G, et al. Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro. PloS One (2014) 9(5):e96925. doi: 10.1371/journal.pone.0096925
    41. Leong DJ, Li YH, Gu XI, Sun L, Zhou Z, Nasser P, et al. Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J (2011) 25(1):182–91. doi: 10.1096/fj.10-164277
    42. He Z, Leong DJ, Xu L, Hardin JA, Majeska RJ, Schaffler MB, et al. CITED2 mediates the cross-talk between mechanical loading and IL-4 to promote chondroprotection. Ann N Y Acad Sci (2019) 1442(1):128–37. doi: 10.1111/nyas.14021
    43. Carey AJ, Tan CK, Ulett GC. Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. Jakstat (2012) 1(3):159–67. doi: 10.4161/jkst.19918
    44. Li X, Kim KW, Cho ML, Ju JH, Kang CM, Oh HJ, et al. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Immunol Lett (2010) 127(2):100–7. doi: 10.1016/j.imlet.2009.10.012
    45. Millward-Sadler SJ, Khan NS, Bracher MG, Wright MO, Salter DM. Roles for the interleukin-4 receptor and associated JAK/STAT proteins in human articular chondrocyte mechanotransduction. Osteoarthritis Cartilage (2006) 14(10):991–1001. doi: 10.1016/j.joca.2006.03.013
    46. Wang L, He C. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front Immunol (2022) 13:967193. doi: 10.3389/fimmu.2022.967193
    47. Butturini E, Carcereri de Prati A, Mariotto S. Redox regulation of STAT1 and STAT3 signaling. Int J Mol Sci(2020) 21(19):7034. doi: 10.3390/ijms21197034
    48. Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med (2013) 54:1–16. doi: 10.1016/j.freeradbiomed.2012.10.553
    49. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J (1998) 334(Pt 2):297–314. doi: 10.1042/bj3340297
    50. Fahy N, de Vries-van Melle ML, Lehmann J, Wei W, Grotenhuis N, Farrell E, et al. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthritis Cartilage (2014) 22(8):1167–75. doi: 10.1016/j.joca.2014.05.021
    51. Dai M, Sui B, Xue Y, Liu X, Sun J. Cartilage repair in degenerative osteoarthritis mediated by squid type II collagen via immunomodulating activation of M2 macrophages, inhibiting apoptosis and hypertrophy of chondrocytes. Biomaterials (2018) 180:91–103. doi: 10.1016/j.biomaterials.2018.07.011
    52. Levinger I, Levinger P, Trenerry MK, Feller JA, Bartlett JR, Bergman N, et al. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum (2011) 63(5):1343–8. doi: 10.1002/art.30287
    53. Huang CY, Lai KY, Hung LF, Wu WL, Liu FC, Ho LJ. Advanced glycation end products cause collagen II reduction by activating janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes. Rheumatol (Oxford) (2011) 50(8):1379–89. doi: 10.1093/rheumatology/ker134
    54. Lim H, Kim HP. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways. Arch Pharm Res (2011) 34(1):109–17. doi: 10.1007/s12272-011-0113-4
    55. De Andrés MC, Imagawa K, Hashimoto K, Gonzalez A, Goldring MB, Roach HI, et al. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun (2011) 407(1):54–9. doi: 10.1016/j.bbrc.2011.02.101
    56. O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med (2015) 66:311–28. doi: 10.1146/annurev-med-051113-024537
    57. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature (2007) 448(7157):1058–62. doi: 10.1038/nature06096
    58. Koskinen-Kolasa A, Vuolteenaho K, Korhonen R, Moilanen T, Moilanen E. Catabolic and proinflammatory effects of leptin in chondrocytes are regulated by suppressor of cytokine signaling-3. Arthritis Res Ther (2016) 18(1):215. doi: 10.1186/s13075-016-1112-0
    59. Andreas K, Häupl T, Lübke C, Ringe J, Morawietz L, Wachtel A, et al. Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther (2009) 11(1): R15. doi: 10.1186/ar2605
    60. Van Beuningen HM, de Vries-van Melle ML, Vitters EL, Schreurs W, van den Berg WB, van Osch GJ, et al. Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditions. Tissue Eng Part A (2014) 20(15-16):2243–52. doi: 10.1089/ten.TEA.2013.0553
    61. Li Y, Tang J, Hu Y. Dimethyl fumarate protection against collagen II degradation. Biochem Biophys Res Commun (2014) 454(2):257–61. doi: 10.1016/j.bbrc.2014.10.005
    62. Maurano, M.T.; Humbert, R.; Rynes, E.; Thurman, R.E.; Haugen, E.; Wang, H.; Reynolds, A.P.; Sandstrom, R.; Qu, H.; Brody, J.; et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA. Science 2012, 337, 1190–1195
    63. Barter MJ, Bui C, Young DA. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012; 20: 339–49.
    64. Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nature reviews. Genetics. 2016 Aug;17(8):487-500. DOI: 10.1038/nrg.2016.59. PMID: 27346641
    65. Cai, Z.; Long, T.; Zhao, Y.; Lin, R.; Wang, Y. Epigenetic Regulation in Knee Osteoarthritis. Front. Genet. 2022, 13, 942982
    66. Hannon E., Gorrie-Stone T. J., Smart M. C., Burrage J., Hughes A., Bao Y., et al. (2018). Leveraging DNA-Methylation Quantitative-Trait Loci to Characterize the Relationship between Methylomic Variation, Gene Expression, and Complex Traits. Am. J. Hum. Genet. 103 (5), 654–665. 10.1016/j.ajhg.2018.09.007
    67. Roach H.I., Aigner T. DNA methylation in osteoarthritic chondrocytes: A new molecular target. Osteoarthr. Cartil. 2007; 15:128–137. doi: 10.1016/j.joca.2006.07.002
    68. Fernandez-Tajes J, Soto-Hermida A, Vazquez-Mosquera ME, Cortes-Pereira E, Mosquera A, Fernandez-Moreno M, et al. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis2014; 73: 668–77
    69. Rushton MD, Reynard LN, Barter MJ, Refaie R, Rankin KS, Young DA, et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol 2014; 66: 2450–60
    70. Roach H.I., Aigner T. DNA methylation in osteoarthritic chondrocytes: A new molecular target. Osteoarthr. Cartil. 2007; 15:128–137. doi: 10.1016/j.joca.2006.07.002
    71. Moazedi-Fuerst F. C., Hofner M., Gruber G., Weinhaeusel A., Stradner M. H., Angerer H., et al. (2014). Epigenetic Differences in Human Cartilage between Mild and Severe OA. J. Orthop. Res. 32 (12), 1636–1645. 10.1002/jor.22722
    72. Kim K.-I., Park Y.-S., Im G.-I. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res. 2013; 28:1050–1060. doi: 10.1002/jbmr.1843
    73. Loeser RF, Im HJ, Richardson B, Lu Q, Chubinskaya S: Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis and cartilage 2009; 17:513–517
    74. Miranda-Duarte A. (2018). DNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications. Open Rheumatol. J. 12, 37–49. 10.2174/1874312901812010037
    75. Hannon E., Gorrie-Stone T. J., Smart M. C., Burrage J., Hughes A., Bao Y., et al. (2018). Leveraging DNA-Methylation Quantitative-Trait Loci to Characterize the Relationship between Methylomic Variation, Gene Expression, and Complex Traits. Am. J. Hum. Genet. 103 (5), 654–665. 10.1016/j.ajhg.2018.09.007
    76. Moazedi-Fuerst F. C., Hofner M., Gruber G., Weinhaeusel A., Stradner M. H., Angerer H., et al. (2014). Epigenetic Differences in Human Cartilage between Mild and Severe OA. J. Orthop. Res. 32 (12), 1636–1645. 10.1002/jor.22722
    77. Fernández-Tajes J., Soto-Hermida A., Vázquez-Mosquera M.E., Cortés-Pereira E., Mosquera A., Fernández-Moreno M., Oreiro N., Fernández-López C., Fernández J.L., Rego-Pérez I., et al. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann. Rheum. Dis. 2014; 73:668–677. doi: 10.1136/annrheumdis-2012-202783.
    78. Wang F, Higgins JM. Histone modifications and mitosis: countermarks, landmarks, and bookmarks. Trends Cell Biol. 2013;23(4):175-84.
    79. Van Rechem C, Whetstine JR (2014) Examining the impact of gene variants on histone lysine methylation. Biochim. Biophys. Acta 1839(12), 1463–76.
    80. Wen, Z.-H.; Huang, J.-S.; Lin, Y.-Y.; Yao, Z.-K.; Lai, Y.-C.; Chen, W.-F.; Liu, H.-T.; Lin, S.-C.; Tsai, Y.-C.; Tsai, T.-C.; et al. Chondroprotective Effects of a Histone Deacetylase Inhibitor, Panobinostat, on Pain Behavior and Cartilage Degradation in Anterior Cruciate Ligament Transection-Induced Experimental Osteoarthritic Rats. Int. J. Mol. Sci. 2021, 22, 7290
    81. Lian, W.-S.; Wu, R.-W.; Ko, J.-Y.; Chen, Y.-S.; Wang, S.-Y.; Yu, C.-P.; Jahr, H.; Wang, F.-S. Histone H3K27 demethylase UTX compromises articular chondrocyte anabolism and aggravates osteoarthritic degeneration. Cell Death Dis. 2022, 13, 538.
    82. Núñez-Carro C., Blanco-Blanco M., Montoya T., Villagrán-Andrade K.M., Hermida-Gómez T., Blanco F.J., de Andrés M.C. Histone Extraction from Human Articular Cartilage for the Study of Epigenetic Regulation in Osteoarthritis. Int. J. Mol. Sci. 2022; 23:3355. doi: 10.3390/ijms23063355.
    83. Wang P., Mao Z., Pan Q., Lu R., Huang X., Shang X., et al. (2018). Histone Deacetylase-4 and Histone Deacetylase-8 Regulate Interleukin-1β-Induced Cartilage Catabolic Degradation through MAPK/JNK and ERK Pathways. Int. J. Mol. Med. 41 (4), 2117–2127. 10.3892/ijmm.2018.3410
    84. Lee S.-H., Lee J.-H., Lee H.-Y., Min K.-J. (2019). Sirtuin Signaling in Cellular Senescence and Aging. BMB Rep. 52 (1), 24–34. 10.5483/bmbrep.2019.52.1.290
    85. He L., Hannon G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004; 5:522–531. doi: 10.1038/nrg1379.
    86. Berezin А.Е. and Eugen I Poplyonkin. Diagnostic and therapeutic value of microRNAs in inflammatory bowel disease. (2020) Biomedical Research and Therapy, 7(2):3622-3632
    87. Lindsay MA. microRNAs and the immune response. Trends Immunol. 2008; 29:343–51
    88. Fernandes-Silva MM, Carvalho VO, Guimarães GV, Bacal F, Bocchi EA. Physical exercise and microRNAs: new frontiers in heart failure. Arq Bras Cardiol. 2012; 98:459–66.
    89. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004; 303:83-86
    90. Zhang C., Zhang Z., Chang Z., Mao G., Hu S., Zeng A., et al. (2019). miR‐193b‐5p Regulates Chondrocytes Metabolism by Directly Targeting Histone Deacetylase 7 in Interleukin‐1β‐induced Osteoarthritis. J Cell. Biochem. 120 (8), 12775–12784. 10.1002/jcb.28545
    91. Dunne A,O’Neill LA.Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett.2005;579:3330-3335
    92. Ceppi M,Pereira PM,Dunand-Sauthier I,Barras E,Reith W,Santos MA,Pierre P.MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA.2009;106:2735-2740
    93. Wang J., Chen L., Jin S., Lin J., Zheng H., Zhang H., et al. (2016). MiR-98 Promotes Chondrocyte Apoptosis by Decreasing Bcl-2 Expression in a Rat Model of Osteoarthritis. Acta Biochim. Biophys. Sin. 48 (10), 923–929. 10.1093/abbs/gmw084
    94. Boros E. and Nagy I.The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019, 8, 1461; doi:10.3390/cells8111461
    95. Wienholds E., Kloosterman W.P., Miska E., Alvarez-Saavedra E., Berezikov E., de Bruijn E., Horvitz H.R., Kauppinen S., Plasterk R.H.A. MicroRNA expression in zebrafish embryonic development. Science. 2005; 309:310–311. doi: 10.1126/science.1114519.
    96. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks. PLoS ONE. 2008;3: e3740. doi: 10.1371/journal.pone.0003740
    97. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M.K., Asahara H. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009; 60:2723–2730. doi: 10.1002/art.24745
    98. Cheleschi S., Barbarino M., Gallo I., Tenti S., Bottaro M., Frati E., Giannotti S., Fioravanti A. Hydrostatic Pressure Regulates Oxidative Stress through microRNA in Human Osteoarthritic Chondrocytes. Int. J. Mol. Sci. 2020; 21:3653. doi: 10.3390/ijms21103653
    99. Kang D., Shin J., Cho Y., Kim H.-S., Gu Y.-R., Kim H., You K.T., Chang M.J., Chang C.B., Kang S.-B., et al. Stress-activated miR-204 governs senescent phenotypes of chondrocytes to promote osteoarthritis development. Sci. Transl. Med. 2019;11: 6659. doi: 10.1126/6659
    100. Huang J., Zhao L., Fan Y., Liao L., Ma P.X., Xiao G., Chen D. The microRNAs miR-204 and miR-211 maintain joint homeostasis and protect against osteoarthritis progression. Nat. Commun. 2019; 10:2876. doi: 10.1038/s41467-019-10753-5.
    101. Yin C.-M., Suen W.-C.-W., Lin S., Wu X.-M., Li G., Pan X.-H. Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity. Bone Jt. Res. 2017; 6:612–618. doi: 10.1302/2046-3758.611.BJR-2017-0090.R1
    102. Li HZ, Lin Z, Xu XH, Lin N, Lu HD. The potential roles of circRNAs in osteoarthritis: a coming journey to find a treasure. Biosci Rep (2018) 38(5): BSR20180542. doi: 10.1042/bsr20180542
    103. Cai Q, Zheng P, Ma F, Zhang H, Li Z, Fu Q, et al. MicroRNA-224 enhances the osteoblastic differentiation of hMSCs via Rac1. Cell Biochem Funct (2019) 37(2):62–71. doi: 10.1002/cbf.3373
    104. Chiu YS, Bamodu OA, Fong IH, Lee WH, Lin CC, Lu CH, et al. The JAK inhibitor tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through mir-149-5p. Bone (2021) 151:116024. doi: 10.1016/j.bone.2021.116024
    105. Zhang L, Sui C, Zhang Y, Wang G, Yin Z. Knockdown of hsa_circ_0134111 alleviates the symptom of osteoarthritis via sponging microRNA-224-5p. Cell Cycle (2021) 20(11):1052–66. doi: 10.1080/15384101.2021.1919838
    106. Du X, Wang X, Cui K, Chen Y, Zhang C, Yao K, et al. Tanshinone IIA and astragaloside IV inhibit miR-223/JAK2/STAT1 signalling pathway to alleviate lipopolysaccharide-induced damage in nucleus pulposus cells. Dis Markers (2021) 2021:6554480. doi: 10.1155/2021/6554480
    107. Zhang B, Tian X, Qu Z, Hao J, Zhang W. Hypoxia-preconditioned extracellular vesicles from mesenchymal stem cells improve cartilage repair in osteoarthritis. Membranes (Basel) (2022) 12(2):225. doi: 10.3390/membranes12020225
    108. D'Adamo S., Alvarez-Garcia O., Muramatsu Y., Flamigni F., Lotz M. K. (2016). MicroRNA-155 Suppresses Autophagy in Chondrocytes by Modulating Expression of Autophagy Proteins. Osteoarthr. Cartil. 24 (6), 1082–1091. 10.1016/j.joca.2016.01.005
    109. Lian L. P., Xi X. Y. (2020). Long Non-coding RNA XIST Protects Chondrocytes ATDC5 and CHON-001 from IL-1β-induced Injury via Regulating miR-653-5p/SIRT1 axis. J. Biol. Regul. Homeost. Agents 34 (2), 379–391. 10.23812/19-549-A-65
    110. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., Kato Y., Sato T., Lotz M.K., Asahara H. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009; 60:2723–2730. doi: 10.1002/art.24745
    111. Lian L. P., Xi X. Y. (2020). Long Non-coding RNA XIST Protects Chondrocytes ATDC5 and CHON-001 from IL-1β-induced Injury via Regulating miR-653-5p/SIRT1 axis. J. Biol. Regul. Homeost. Agents 34 (2), 379–391. 10.23812/19-549-A-65
    112. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., Yasunaga Y., Asahara H., Ochi M. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum. 2009; 60:1035–1041. doi: 10.1002/art.24404
    113. Bartholomew B. ISWI chromatin remodeling: one primary actor or a coordinated effort? Curr Opin Struct Biol. 2014; 24:150-153
    114. Wang, G.; He, L.; Xiang, Y.; Jia, D.; Li, Y. Long noncoding and micro-RNA expression in a model of articular chondrocyte degeneration induced by stromal cell-derived factor-1. Asian Biomed. Res. Rev. News 2022, 16, 169–179
    115. Zhang H, Ji L, Yang Y, Wei Y, Zhang X, Gang Y, Lu J, Bai L. The therapeutic effects of treadmill exercise on osteoarthritis in rats by inhibiting the HDAC3/NF-kappaB pathway in vivo and in vitro. Frontiers in Physiology201910 1060. (10.3389/fphys.2019.01060)
    116. Kim, D.; Song, J.; Jin, E.-J. BNIP3-Dependent Mitophagy via PGC1α Promotes Cartilage Degradation. Cells 2021, 10, 1839
    117. Cheng, M.; Wang, Y. Downregulation of HMGB1 by miR-103a-3p Promotes Cell Proliferation, Alleviates Apoptosis and in Flammation in a Cell Model of Osteoarthritis. Iran J. Biotechnol. 2020, 18, 24–31
    118. Endisha, H.; Datta, P.; Sharma, A.; Nakamura, S.; Rossomacha, E.; Younan, C.; Ali, S.A.; Tavallaee, G.; Lively, S.; Potla, P.; et al. MicroRNA-34a-5p Promotes Joint Destruction During Osteoarthritis. Arthritis Rheumatol. 2020, 73, 426–439
    119. Tavallaee, G.; Lively, S.; Rockel, J.S.; Ali, S.A.; Im, M.; Sarda, C.; Mitchell, G.M.; Rossomacha, E.; Nakamura, S.; Potla, P.; et al. Contribution of MicroRNA-27b-3p to Synovial Fibrotic Responses in Knee Osteoarthritis. Arthritis Rheumatol. 2022, 74, 1928–1942
    120. Jin, Y.; Xu, M.; Zhu, H.; Dong, C.; Ji, J.; Liu, Y.; Deng, A.; Gu, Z. Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. J. Cell. Mol. Med. 2021, 25, 9281–9294
    121. Wang B., Li J., Tian F. (2021). Downregulation of lncRNA SNHG14 Attenuates Osteoarthritis by Inhibiting FSTL-1 Mediated NLRP3 and TLR4/NF-Κb Pathway through miR-124-3p. Life Sci. 270, 119143. 10.1016/j.lfs.2021.119143
    122. Wang C.-L., Zuo B., Li D., Zhu J.-F., Xiao F., Zhang X.-L., et al. (2020). The Long Noncoding RNA H19 Attenuates Force-Driven Cartilage Degeneration via miR-483-5p/Dusp5. Biochem. Biophysical Res. Commun. 529 (2), 210–217. 10.1016/j.bbrc.2020.05.180.
    123. He X. et al. (2020) Single-cell omics in ageing: a young and growing field. Nat. Metab. 2, 293–302; Ma, S. et al. (2023) Decoding aging hallmarks at the single-cell level. Annu. Rev. Biomed. Data Sci. 6, 129–152
    124. Liu Y., Yang Y., Ding L., Jia Y., Ji Y. (2020a). LncRNA MIR4435-2HG Inhibits the Progression of Osteoarthritis through miR-510-3p Sponging. Exp. Ther. Med. 20 (2), 1693–1701. 10.3892/etm.2020.8841
    125. Liu Y., Liu K., Tang C., Shi Z., Jing K., Zheng J. (2020b). Long Non-coding RNA XIST Contributes to Osteoarthritis Progression via miR-149-5p/DNMT3A axis. Biomed. Pharmacother. 128, 110349. 10.1016/j.biopha.2020.110349
    126. Zhang Y., Fukui N., Yahata M., Katsuragawa Y., Tashiro T., Ikegawa S., et al. (2016). Identification of DNA Methylation Changes Associated with Disease Progression in Subchondral Bone with Site-Matched Cartilage in Knee Osteoarthritis. Sci. Rep. 6, 34460. 10.1038/srep34460
    127. Simon T. C., Jeffries M. A. (2017). The Epigenomic Landscape in Osteoarthritis. Curr. Rheumatol. Rep. 19 (6), 30. 10.1007/s11926-017-0661-9
    128. Parker E., Hofer I. M. J., Rice S. J., Earl L., Anjum S. A., Deehan D. J., et al. (2021). Multi‐Tissue Epigenetic and Gene Expression Analysis Combined with Epigenome Modulation Identifies RWDD2B as a Target of Osteoarthritis Susceptibility
    129. Ramos, Y.F.; Meulenbelt, I. The role of epigenetics in osteoarthritis: Current perspective. Curr. Opin. Rheumatol. 2017, 29, 119–129

Downloads

Download data is not yet available.